This study uncovers the existence of a selectively vulnerable subtype of dopaminergic neurons (DANs) that is sufficient to drive early motor symptoms in Parkinson’s disease.
LID is poorly understood, our research on dyskinetic mice show SPNs' properties oscillate during LID and are influenced by dopamine and acetylcholine signaling. Targeting M1 receptors in iSPNs reduced LID severity and improved levodopa effects.